Nerviano, Italy

Valter Domenico Croci


 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Valter Domenico Croci: Innovator in Antineoplastic Therapeutics

Introduction

Valter Domenico Croci is a notable inventor based in Nerviano, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic combinations for cancer treatment. With a total of two patents to his name, Croci's work focuses on innovative approaches to combat tumors.

Latest Patents

Croci's latest patents include a therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent. This invention provides a combination that includes a compound of formula (I) and one or more antineoplastic agents, which are useful in the treatment of tumors. The active ingredients can be present in free form or as pharmaceutically acceptable salts or hydrates. His second patent involves a therapeutic combination comprising a CDKS inhibitor and an antineoplastic agent. This combination also includes a compound of formula (I) and various antineoplastic agents, with the active ingredients available in free form or as pharmaceutically acceptable salts.

Career Highlights

Valter Domenico Croci is associated with Nerviano Medical Sciences S.r.l., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, contributing to the creation of effective treatment options.

Collaborations

Some of Croci's notable coworkers include Enrico Pesenti and Barbara Valsasina. Their collaborative efforts enhance the innovative environment at Nerviano Medical Sciences S.r.l.

Conclusion

Valter Domenico Croci's contributions to the field of antineoplastic therapeutics exemplify the impact of innovation in medicine. His patents reflect a commitment to improving cancer treatment through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…